cephalosporins
C and G, clavulanic acid, nocardicin A and thienamycin against Escherichia coil KN-126 and Bacillus megaterium KM peptidoglycan transpeptidases were studied. Their modes of action against E. coil are discussed on the basis of the results and the published binding data for penicillin binding proteins. The effects of modifications at position 3 and 7
of the cephalosporin and those at a-carbon of the benzyl side-chain of cephalosporin G and penicillin G were studied. The introduction of an amino group at this position in cephalosporin G together with the removal of an acetoxy group from the acetoxymethyl group at position 3 reduced the inhibitory activity against E. coli transpeptidase considerably. Their joint inhibition by B-lactams results in cell lysis and spheroplast formation. PBPs 2 and 3 are involved in the maintenance of shape and in the cell division process, respectively. The TPase detectable in the membrane fraction from E. coli was shown to correspond to PBP 1Bs4, 9, 10) Since the demonstration of the inhibition of E. coil TPase by B-lactam antibiotics"" many workers have reported the inhibition in different strains of E. coli and in other species of bacteria. However, most of these studies are either not extensive or are unreliable because of the assay methods used for the determinations of cross-linking10,11). We have studied the effect of many natural and semi-synthetic B -lactam antibiotics on the in vitro TPase in E . coli KN-126 and Bacillus megaterium KM with our improved method10,12). The results will be reported here and discussed in relation to the structureactivity relationships.
Methods and Materials
Organisms, growth and preparation of particulate fractions E. coil KN-126 and B. megaterium were grown, harvested and stored as described previously10,12)
Particulate fractions were prepared from the frozen cells by alumina grinding as previously reported10).
Assay of polymerization and cross-linking Table 1) .
The above results together with published data for the penicillin binding proteins in E . coli KN-1267,13) indicate that the action of the representative B-lactam compounds can be characterized as follows .
Pen G has a nearly equal affinity toward the three possible lethal targets in E . coli, namely PBP 1Bs, PBP 2 and PBP 3. Cephalosporin G (CP-G) has the highest affinity toward PBP 3. Its high affinity toward PBP 1 (later resolved into 1A and 1Bs14)) can be explained by the affinity toward PBP 1A , which is functionally interchangeable with 1Bs but has higher affinity toward B-lactams . The affinity toward PBP 2 is the least, (This situation will be described as follows: 3> 1Bs> 2). Like mecillinam, clavulanic acid is a specific inhibitor of PBP 2 function(s)13) and its affinities toward other PBPs will not contribute to its antimicrobial action against E. coli (2>> 1 Bs, 3). Thienamycin has the highest affinity toward PBP 2, but its high inhibitory activity against the in vitro TPase
(1 Bs) may contribute to its antimicrobial activity (2> 1 Bs >> 3).
Effects of the Introduction of a
7-a-Methoxy Group
The introduction of a 7-methoxy group into cephalosporins increased the inhibitory Table 2 ). The introduction did not affect the activity toward B. megaterium TPase.
Since an increased inhibitory activity against E.
coli TPase was not always reflected in the antimicrobial activity, a poor permeability was assumed15 In some cases the introduction of a 7-methoxy group increases the affinity toward PBP 1Bs (the in vitro TPase) with a considerable decrease in the affinity toward PBP 3. In other cases, the introduction decreases the affinities toward both PBPs, but the decrease in the affinity toward PBP 1Bs is less16). In rare cases it increases the affinity toward PBP 1Bs with little or no decrease in the affinity toward PBP 3. Whichever the case, the ratio of the affinity toward PBP lBs to that of PBP 3 will be increased by the introduction of a methoxy group to cephalosporins.
Consequently the lower concentration range where elongation is mainly observed with corresponding 7-H cephalosporins becomes narrower or disappears and lysis is observed as the earliest event.
Effects of Substitutions at Position 3 of Cephalosporins Cephalosporin C (CP-C), deacetyl CP-C and deacetoxy CP-C show decreasing inhibitory activity against E. coli TPase in this order (Table 3 ). The substitution of the acetyl group with a carbamoyl group increases the inhibitory activity slightly against E. coli TPase and significantly against B. megaterium TPase. This relationship will also hold true for the substitution at position 3 of cephamycins A-16886 I=cephamycin C (7-(5-amino-5-carboxyvaleramido)-7-methoxy-3-carbamoyloxymethyl-3-cephem-4-carboxylic acid). Each pair differs only by the presence of a 7-methoxy group.
-, not determined. megaterium TPases (Table 4) . Also, the intro- Comparison of Cephachlor with Cephalexin The introduction of an a-amino group into the benzyl side-chain of CP-G together with the removal of an acetoxy group from the acetoxymethyl group at position 3 of CP-G considerably reduced the inhibitory activity of the resultant compound (cephalexin) against E. coli TPase (Table 3) . These modifications did not impair the affinity toward PBP 3 and might increase it. Thus cephalexin remains The affinities toward PBP 1Bs and 3 were increased 55-fold and 4-fold respectively17). With these changes, the antibacterial activity increased only twofold or so in terms of MIC17).
However, cells of growing E. coli KN-126 lysed rapidly at 25 ug of cephachlor or less per ml, whereas they lysed at 250 ug of cephalexin per ml (Fig. 1) . ROLINSON18) observed lysis of filamentous cells of E. coli at low concentrations of cephalexin (2-50 x MIC) and rapid lysis of short cells at higher concentrations (around 200 x MIC). He suggested that the lysis of these two forms of E. coli might be due to two different processes. Indeed, the rapid lysis can be explained by the inhibition of the in vitro TPase (PBP 1Bs), while the lysis at low concentrations will be ascribed to the inhibition of PBP 3 function(s) (septum formation). How the improvement in the inhibitory activity of cephachlor against E. coli
TPase is reflected in the clinical situation remains to be seen.
